Detalhe da pesquisa
1.
Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.
Diabetes Obes Metab
; 23(9): 2090-2098, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047449
2.
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
Diabetes Obes Metab
; 23(6): 1272-1281, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528904
3.
A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
Diabetes Care
; 46(7): 1372-1378, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134305
4.
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.
Nat Med
; 28(6): 1269-1276, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551290
5.
Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial.
Diabetes Technol Ther
; 23(3): 168-174, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050728